Yantai Zhenghai Bio-Tech Co Ltd (300653) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yantai Zhenghai Bio-Tech Co Ltd (300653) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥30.47 Million ≈ $4.46 Million USD) by net assets (CN¥874.47 Million ≈ $127.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300653 stock market capitalisation for the company's overall valuation and market capitalisation.
Yantai Zhenghai Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Yantai Zhenghai Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yantai Zhenghai Bio-Tech Co Ltd ranked by their cash flow conversion efficiency. Explore Yantai Zhenghai Bio-Tech Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shandong Xinjufeng Technology Packaging Co. Ltd. A
SHE:301296
|
N/A |
|
Bumble Inc
NASDAQ:BMBL
|
0.087x |
|
ASTON MART.LA.UADR LS-001
F:A5S0
|
0.262x |
|
Guangdong Liantai Environmental Protection Co Ltd
SHG:603797
|
0.040x |
|
Guangdong Dcenti Auto-Parts Stock Ltd Co
SHG:603335
|
0.088x |
|
Mercurity Fintech Holding Inc ADR
NASDAQ:MFH
|
-0.118x |
|
Ciwen Media Co Ltd
SHE:002343
|
-0.057x |
|
Electra Co Pr
TA:ECP
|
0.041x |
Annual Cash Flow Conversion Efficiency for Yantai Zhenghai Bio-Tech Co Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2025. View 300653 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥889.48 Million ≈ $130.16 Million |
CN¥97.19 Million ≈ $14.22 Million |
0.109x | -35.85% |
| 2024-12-31 | CN¥888.78 Million ≈ $130.06 Million |
CN¥151.38 Million ≈ $22.15 Million |
0.170x | -10.53% |
| 2023-12-31 | CN¥948.07 Million ≈ $138.73 Million |
CN¥180.48 Million ≈ $26.41 Million |
0.190x | -12.33% |
| 2022-12-31 | CN¥865.11 Million ≈ $126.59 Million |
CN¥187.84 Million ≈ $27.49 Million |
0.217x | +2.63% |
| 2021-12-31 | CN¥785.27 Million ≈ $114.91 Million |
CN¥166.13 Million ≈ $24.31 Million |
0.212x | +15.53% |
| 2020-12-31 | CN¥646.72 Million ≈ $94.64 Million |
CN¥118.43 Million ≈ $17.33 Million |
0.183x | +4.13% |
| 2019-12-31 | CN¥588.38 Million ≈ $86.10 Million |
CN¥103.48 Million ≈ $15.14 Million |
0.176x | +20.10% |
| 2018-12-31 | CN¥529.00 Million ≈ $77.41 Million |
CN¥77.47 Million ≈ $11.34 Million |
0.146x | +8.07% |
| 2017-12-31 | CN¥483.18 Million ≈ $70.70 Million |
CN¥65.47 Million ≈ $9.58 Million |
0.136x | -37.22% |
| 2016-12-31 | CN¥228.16 Million ≈ $33.39 Million |
CN¥49.25 Million ≈ $7.21 Million |
0.216x | -15.34% |
| 2015-12-31 | CN¥179.40 Million ≈ $26.25 Million |
CN¥45.74 Million ≈ $6.69 Million |
0.255x | -47.32% |
| 2014-12-31 | CN¥63.62 Million ≈ $9.31 Million |
CN¥30.79 Million ≈ $4.51 Million |
0.484x | -58.71% |
| 2013-12-31 | CN¥29.34 Million ≈ $4.29 Million |
CN¥34.38 Million ≈ $5.03 Million |
1.172x | +133.32% |
| 2012-12-31 | CN¥-6.43 Million ≈ $-941.02K |
CN¥22.62 Million ≈ $3.31 Million |
-3.517x | -- |
About Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral restoration membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etching agent, dental pit and fissure sealant, active biol… Read more